Synopsis of recent research by authors named "Ruohang Weng"
- Ruohang Weng's recent research primarily focuses on pediatric rheumatology and the impact of autoimmune diseases and infections in children, as evidenced by studies on COVID-19 in pediatric patients with rheumatic diseases, and treatment efficacy of canakinumab for conditions like systemic juvenile idiopathic arthritis and cryopyrin-associated periodic syndrome.
- The research also delves into the causes and treatment of juvenile arthritis related to genetic factors, specifically examining LACC1 mutations, and highlighting significant inflammatory markers and immune responses in affected patients.
- Further, Weng's studies explore opportunistic infections in children with inborn errors of immunity, contributing to a deeper understanding of rare infections like Talaromyces marneffei, as well as inflammatory responses in acute-phase conditions such as Kawasaki disease, thereby linking immune dysregulation and clinical outcomes.
